Shares of Exchange Income Co. (TSE:EIF – Get Free Report) have been assigned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is C$70.50.
Several brokerages have recently commented on EIF. Canaccord Genuity Group lifted their target price on Exchange Income from C$75.00 to C$77.00 and gave the stock a “buy” rating in a research report on Thursday, May 22nd. TD Securities lifted their target price on Exchange Income from C$68.00 to C$70.00 and gave the stock a “buy” rating in a research report on Thursday, May 22nd. Royal Bank Of Canada lifted their target price on Exchange Income from C$64.00 to C$66.00 and gave the stock an “outperform” rating in a research report on Thursday, May 22nd. ATB Capital lifted their target price on Exchange Income from C$68.00 to C$70.00 and gave the stock an “outperform” rating in a research report on Thursday, May 22nd. Finally, Scotiabank lifted their target price on Exchange Income from C$64.00 to C$66.00 and gave the stock an “outperform” rating in a research report on Thursday, May 22nd.
Get Our Latest Research Report on Exchange Income
Exchange Income Price Performance
Exchange Income Company Profile
Exchange Income Corp is a diversified acquisition-oriented corporation focused on opportunities in two sectors, aerospace, aviation services and equipment, and manufacturing. The business plan of the corporation is to invest in profitable, well-established companies with strong cash flows operating in niche markets.
Featured Articles
- Five stocks we like better than Exchange Income
- Retail Stocks Investing, Explained
- AutoNation: Growth Engines Make It an Undervalued Stock
- 3 Tickers Leading a Meme Stock Revival
- Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
- There Are Different Types of Stock To Invest In
- 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Receive News & Ratings for Exchange Income Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exchange Income and related companies with MarketBeat.com's FREE daily email newsletter.